STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
CPRX CATALYST PHARMACEUTICAL PARTNERS INCO StockScouter® Report
3
StockScouter® Score
CATALYST PHARMACEUTICAL PARTNERS INCO, a small cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
Concerns
- One or more analysts has significantly decreased quarterly earnings estimates for CPRX. Negative
- Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
- Two or more executives, directors or major shareholders sold a large number of shares recently. Very negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
D
F
D
C